<?xml version="1.0" encoding="UTF-8"?>
<project>
  <language>en</language>
  <availableLanguages readOnly="true">en</availableLanguages>
  <rcn>256894</rcn>
  <id>101123166</id>
  <acronym>Tune_IT</acronym>
  <teaser>Adoptive cell therapy (ACT) recently became an important treatment modality for cancer . Since 2017, several chimeric antigen receptor (CAR)-T cell therapies approved by the FDA/EMA and more are expected to receive approval for clinical use. Currently, more than 250 clinical...</teaser>
  <objective><![CDATA[Adoptive cell therapy (ACT) recently became an important treatment modality for cancer . Since 2017, several chimeric antigen receptor (CAR)-T cell therapies approved by the FDA/EMA and more are expected to receive approval for clinical use. Currently, more than 250 clinical ACT trials are ongoing. Already in 2021, the market size was >$1 billion and is expected to  grow tremendously to >$25 billion  by 2030. ACT products require extensive ex vivo manipulation and expansion of patient derived T cells prior to reinfusion back into patients to attack cancer cells. Unfortunately, T cell exhaustion and loss of function after reinfusion form a major problem in currently used ex vivo expansion protocols.

The solution. 
Dedicated tuning of T cells during ex vivo expansion to preserve their anti- cancer function and prevent exhaustion. In the body, T cells are activated by antigen presenting cells (APC) to initiate an immune response. As patient-derived APC are often immunosuppressed, much effort is spent on developing 'artificial antigen presenting cells' (aAPC) to expand immune cells for ACT. We developed a unique polymeric aAPC platform, termed immunofilaments, that provide a highly flexible-, scalable-, GMP compliant- and affordable- solution for robust production of T cells for ACT. Our initial findings indeed indicate that we can diminish T cell exhaustion and outcompete products currently used in the clinic for ex vivo T cell expansion.

Tune-IT will validate the technical and commercial feasibility of this novel technology platform that exploits immunofilaments to significantly improve function and longevity of ACT products in patients. 
In Tune-IT, we will: 1) demonstrate that tuning of ex vivo cultured therapeutic T cells will prevent exhaustion and loss of tumor killing capacity after reinfusing T cells and 2) perform market and business case analyses to ensure commercial feasibility and market entry through Simmunext Biotherapeutics, a Radboudumc spin-off]]></objective>
  <title>Tuning Immune T cells for cancer therapy</title>
  <totalCost>0</totalCost>
  <ecMaxContribution>150000</ecMaxContribution>
  <startDate>2024-01-01</startDate>
  <endDate>2025-06-30</endDate>
  <ecSignatureDate>2023-07-18</ecSignatureDate>
  <duration>18</duration>
  <status>SIGNED</status>
  <identifiers>
    <grantDoi>10.3030/101123166</grantDoi>
  </identifiers>
  <validation>
    <euroSciVoc>false</euroSciVoc>
  </validation>
  <sourceUpdateDate>2024-12-31 09:30:22</sourceUpdateDate>
  <contentCreationDate readOnly="true">2023-09-19 19:01:16</contentCreationDate>
  <contentUpdateDate>2023-09-19 19:01:11</contentUpdateDate>
  <lastUpdateDate readOnly="true">2025-11-03 09:43:38</lastUpdateDate>
  <relations>
    <associations>
      <article source="editorial" type="relatedArticle">
        <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
        <rcn>456036</rcn>
        <id>456036-immune-platform-for-improved-adoptive-cell-therapy</id>
        <title>Immune platform for improved adoptive cell therapy</title>
        <contentUpdateDate>2025-05-08 13:26:00</contentUpdateDate>
        <relations>
          <categories>
            <category classification="applicationDomain" type="isApplicableIn">
              <language>en</language>
              <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
              <code>/health</code>
              <title>Health</title>
              <displayCode readOnly="true">/Health</displayCode>
            </category>
            <category classification="collection" type="belongsTo">
              <language>en</language>
              <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
              <code>/projectDescription</code>
              <title>Project description</title>
              <description>Article: description of linked project written by editorial team</description>
              <displayCode readOnly="true">/Project description</displayCode>
            </category>
            <category classification="source" type="isProvidedBy">
              <language>en</language>
              <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
              <code>/editorial</code>
              <title>CORDIS Editorial</title>
              <description>Written by CORDIS</description>
              <displayCode readOnly="true">/CORDIS Editorial</displayCode>
            </category>
          </categories>
        </relations>
      </article>
      <call source="corda" type="relatedMasterCall">
        <rcn>55832</rcn>
        <title>ERC-2023-POC</title>
        <identifier>ERC-2023-POC</identifier>
      </call>
      <call source="corda" type="relatedSubCall">
        <rcn>55832</rcn>
        <title>ERC-2023-POC</title>
        <identifier>ERC-2023-POC</identifier>
      </call>
      <organization source="corda" order="1" ecContribution="150000" terminated="false" sme="false" netEcContribution="150000" totalCost="0" type="coordinator">
        <availableLanguages readOnly="true">en</availableLanguages>
        <rcn>1969372</rcn>
        <id>892057785</id>
        <vatNumber>NL861608884B01</vatNumber>
        <legalName>STICHTING RADBOUD UNIVERSITAIR MEDISCH CENTRUM</legalName>
        <shortName>RADBOUDUMC</shortName>
        <address>
          <street>GEERT GROOTEPLEIN 10 ZUID</street>
          <city>NIJMEGEN</city>
          <postalCode>6525 GA</postalCode>
          <country>NL</country>
          <geolocation>51.8236065,5.8598165</geolocation>
        </address>
        <relations>
          <categories>
            <category classification="organizationActivityType" type="relatedOrganizationActivityType">
              <language>en</language>
              <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
              <code>/HES</code>
              <title>Higher or Secondary Education Establishments</title>
              <displayCode readOnly="true">/Higher or Secondary Education Establishments</displayCode>
            </category>
          </categories>
          <regions>
            <region type="relatedNutsCode">
              <name>Arnhem/Nijmegen</name>
              <rcn>391389318</rcn>
              <nutsCode>NL226</nutsCode>
              <parents>
                <region>
                  <name>Gelderland</name>
                  <rcn>391389352</rcn>
                  <nutsCode>NL22</nutsCode>
                  <parents>
                    <region>
                      <name>Oost-Nederland</name>
                      <rcn>391391784</rcn>
                      <nutsCode>NL2</nutsCode>
                      <parents>
                        <region>
                          <name>Netherlands</name>
                          <rcn>391547432</rcn>
                          <nutsCode>NL</nutsCode>
                          <euCode>NL</euCode>
                          <isoCode>NL</isoCode>
                        </region>
                      </parents>
                    </region>
                  </parents>
                </region>
              </parents>
            </region>
            <region type="relatedRegion">
              <name>Netherlands</name>
              <rcn>391547432</rcn>
              <nutsCode>NL</nutsCode>
              <euCode>NL</euCode>
              <isoCode>NL</isoCode>
            </region>
          </regions>
        </relations>
      </organization>
      <programme source="corda" uniqueProgrammePart="true" type="relatedLegalBasis">
        <availableLanguages readOnly="true">en</availableLanguages>
        <rcn>705727</rcn>
        <id>HORIZON.1.1</id>
        <code>HORIZON.1.1</code>
        <frameworkProgramme>HORIZON</frameworkProgramme>
        <pga>HORIZON.1.1</pga>
        <title>European Research Council (ERC)</title>
        <parent>
          <programme>
            <rcn>705726</rcn>
            <code>HORIZON.1</code>
            <parent>
              <programme>
                <rcn>705725</rcn>
                <code>HORIZON</code>
              </programme>
            </parent>
          </programme>
        </parent>
        <relations>
          <categories>
            <category classification="collection" type="belongsTo">
              <language>en</language>
              <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
              <code>/legalbasis</code>
              <title>Legal Basis</title>
              <description>Programme: Legal basis for research funding</description>
              <displayCode readOnly="true">/Legal Basis</displayCode>
            </category>
            <category classification="source" type="isProvidedBy">
              <language>en</language>
              <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
              <code>/corda</code>
              <title>CORDA</title>
              <description>RTD research data warehouse</description>
              <displayCode readOnly="true">/CORDA</displayCode>
            </category>
          </categories>
        </relations>
      </programme>
      <programme source="corda" type="relatedTopic">
        <availableLanguages readOnly="true">en</availableLanguages>
        <rcn>707186</rcn>
        <id>HORIZON_ERC-2023-POC</id>
        <code>ERC-2023-POC</code>
        <frameworkProgramme>HORIZON</frameworkProgramme>
        <title>ERC PROOF OF CONCEPT GRANTS</title>
        <parent>
          <programme>
            <rcn>20300</rcn>
            <code>HORIZON-Topics</code>
          </programme>
        </parent>
        <relations>
          <categories>
            <category classification="collection" type="belongsTo">
              <language>en</language>
              <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
              <code>/topic</code>
              <title>Topic</title>
              <description>Programme: Part of the Commission work programme implementing legal basis</description>
              <displayCode readOnly="true">/Topic</displayCode>
            </category>
            <category classification="source" type="isProvidedBy">
              <language>en</language>
              <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
              <code>/corda</code>
              <title>CORDA</title>
              <description>RTD research data warehouse</description>
              <displayCode readOnly="true">/CORDA</displayCode>
            </category>
          </categories>
        </relations>
      </programme>
      <result source="corda" type="relatedResult">
        <availableLanguages readOnly="true">en</availableLanguages>
        <rcn>1352519</rcn>
        <id>101123166_213480_PUBLIHORIZON</id>
        <title>Immunofilaments Are Well Tolerated after Local or Systemic Administration in Mice</title>
        <details>
          <authors>Lea Weiss, René Classens, Marjolein Schluck, Emilia Grad, Yusuf Dölen, Lieke van der Woude, Dominique van Midden, Lisa Maassen, Kiek Verrijp, Koen van Riessen, Eric van Dinther, Philipp M. Hagemann, Carl G. Figdor, Roel Hammink</authors>
          <journalNumber>7</journalNumber>
          <journalTitle>ACS Pharmacology &amp;amp; Translational Science</journalTitle>
          <publishedPages/>
          <publishedYear>2024</publishedYear>
          <publisher>American Chemical Society (ACS)</publisher>
        </details>
        <identifiers>
          <doi>10.1021/ACSPTSCI.4C00180</doi>
          <issn>2575-9108</issn>
        </identifiers>
        <sourceUpdateDate>2025-08-25 08:12:51</sourceUpdateDate>
        <contentUpdateDate>2025-09-01 11:10:48</contentUpdateDate>
        <relations>
          <categories>
            <category classification="collection" type="belongsTo">
              <language>en</language>
              <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
              <code>/publication</code>
              <title>Project publication</title>
              <description>Result: Project publications</description>
              <displayCode readOnly="true">/Project publication</displayCode>
            </category>
            <category classification="projectPublication" type="isPublishedAs">
              <language>en</language>
              <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
              <code>/PEER_REVIEWED_ARTICLE</code>
              <title>Peer reviewed articles</title>
              <displayCode readOnly="true">/Peer reviewed articles</displayCode>
            </category>
            <category classification="source" type="isProvidedBy">
              <language>en</language>
              <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
              <code>/corda</code>
              <title>CORDA</title>
              <description>RTD research data warehouse</description>
              <displayCode readOnly="true">/CORDA</displayCode>
            </category>
          </categories>
        </relations>
      </result>
      <result source="corda" type="relatedResult">
        <availableLanguages readOnly="true">en</availableLanguages>
        <rcn>1374943</rcn>
        <id>101123166_PSHORIZON</id>
        <title>Periodic Reporting for period 1 - Tune_IT (Tuning Immune T cells for cancer therapy)</title>
        <teaser>The problem: Loss of function of adoptively transferred T cells for cancer immunotherapy. Adoptive cell therapy (ACT) recently became an important treatment modality for cancer. Over 400 clinical ACT trials are ongoing mainly exploiting T cells, now also expanding to other...</teaser>
        <description>periodic</description>
        <sourceUpdateDate>2025-10-20 17:42:54</sourceUpdateDate>
        <contentUpdateDate>2025-10-27 12:14:14</contentUpdateDate>
        <relations>
          <categories>
            <category classification="collection" type="belongsTo">
              <language>en</language>
              <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
              <code>/pubsum</code>
              <title>Report Summary</title>
              <description>Result: Publishable summary (FP7 SESAM) and Summary for publication (H2020 SyGMa)</description>
              <displayCode readOnly="true">/Report Summary</displayCode>
            </category>
            <category classification="source" type="isProvidedBy">
              <language>en</language>
              <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
              <code>/corda</code>
              <title>CORDA</title>
              <description>RTD research data warehouse</description>
              <displayCode readOnly="true">/CORDA</displayCode>
            </category>
          </categories>
        </relations>
      </result>
      <result source="corda" type="relatedResult">
        <availableLanguages readOnly="true">en</availableLanguages>
        <rcn>1352518</rcn>
        <id>101123166_213476_PUBLIHORIZON</id>
        <title>Interleukin-12 decorated nanosized semiflexible Immunofilaments enable directed targeting and augmented IFNγ responses of natural killer cells</title>
        <details>
          <authors>Lea Weiss, Marjolein Schluck, René Classens, Paul K.J.D. de Jonge, Anniek van der Waart, Khue G. Nguyen, Tam T. Nguyen, David A. Zaharoff, Karl-Johan Malmberg, Harry Dolstra, Carl G. Figdor, Ebba Sohlberg, Roel Hammink</authors>
          <journalNumber>191</journalNumber>
          <journalTitle>Acta Biomaterialia</journalTitle>
          <publishedPages/>
          <publishedYear>2024</publishedYear>
          <publisher>Elsevier BV</publisher>
        </details>
        <identifiers>
          <doi>10.1016/J.ACTBIO.2024.11.012</doi>
          <issn>1742-7061</issn>
        </identifiers>
        <sourceUpdateDate>2025-08-25 08:12:51</sourceUpdateDate>
        <contentUpdateDate>2025-09-01 11:10:48</contentUpdateDate>
        <relations>
          <categories>
            <category classification="collection" type="belongsTo">
              <language>en</language>
              <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
              <code>/publication</code>
              <title>Project publication</title>
              <description>Result: Project publications</description>
              <displayCode readOnly="true">/Project publication</displayCode>
            </category>
            <category classification="projectPublication" type="isPublishedAs">
              <language>en</language>
              <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
              <code>/PEER_REVIEWED_ARTICLE</code>
              <title>Peer reviewed articles</title>
              <displayCode readOnly="true">/Peer reviewed articles</displayCode>
            </category>
            <category classification="source" type="isProvidedBy">
              <language>en</language>
              <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
              <code>/corda</code>
              <title>CORDA</title>
              <description>RTD research data warehouse</description>
              <displayCode readOnly="true">/CORDA</displayCode>
            </category>
          </categories>
        </relations>
      </result>
    </associations>
    <categories>
      <category classification="collection" type="belongsTo">
        <language>en</language>
        <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
        <code>/project</code>
        <title>Project</title>
        <description>Project factsheets</description>
        <displayCode readOnly="true">/Project</displayCode>
      </category>
      <category classification="euroSciVoc" type="isInFieldOfScience">
        <language>en</language>
        <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
        <code>/21/39/225</code>
        <title>oncology</title>
        <displayCode readOnly="true">/medical and health sciences/clinical medicine/oncology</displayCode>
      </category>
      <category weight="0" classification="policyPriorities" type="marker">
        <language>en</language>
        <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
        <code>/digitalAgenda</code>
        <title>Digital agenda</title>
        <description>This tracker monitors Horizon Europe’s financial contribution to the development of digital technologies and the digitisation of the economy and society (known as ‘Digital transition’).</description>
        <displayCode readOnly="true">/Digital agenda</displayCode>
      </category>
      <category weight="0" classification="policyPriorities" type="marker">
        <language>en</language>
        <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
        <code>/cleanAir</code>
        <title>Clean air</title>
        <description>This tracker monitors the Horizon Europe’s financial contribution to the clean air policy (National Emission Ceiling Directive) aiming to improve ambient air quality and tackle air pollution, to protect the environment and human health.</description>
        <displayCode readOnly="true">/Clean air</displayCode>
      </category>
      <category weight="0" classification="policyPriorities" type="marker">
        <language>en</language>
        <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
        <code>/ai</code>
        <title>Artificial intelligence</title>
        <description>This tracker monitors Horizon Europe’s financial contribution to the development and deployment of AI-based technologies and solutions. Projects that develop AI-tools as part of their research method are included</description>
        <displayCode readOnly="true">/Artificial intelligence</displayCode>
      </category>
      <category weight="0" classification="policyPriorities" type="marker">
        <language>en</language>
        <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
        <code>/climate</code>
        <title>Climate action</title>
        <description>This tracker monitors the Horizon Europe’s financial contribution to both mitigating climate change (e.g., contributions to the reduction of greenhouse gas emissions) and adapting to climate change by building resilience (e.g., regarding floods, droughts, spatial planning and better governance, adaptation to changing climate in value chains, etc.).</description>
        <displayCode readOnly="true">/Climate action</displayCode>
      </category>
      <category weight="0" classification="policyPriorities" type="marker">
        <language>en</language>
        <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
        <code>/biodiversity</code>
        <title>Biodiversity</title>
        <description>This tracker monitors the Horizon Europe’s financial contribution to Europe’s biodiversity’s path to recovery including species protection, ecosystem conservation, and habitat rehabilitation, all essential for resilience in climate adaptation and addressing ecosystem services but also environmental crime and the health-environment connection.</description>
        <displayCode readOnly="true">/Biodiversity</displayCode>
      </category>
      <category classification="projectFundingSchemeCategory" type="relatedProjectFundingSchemeCategory">
        <language>en</language>
        <availableLanguages readOnly="true">en</availableLanguages>
        <code>/HORIZON-ERC-POC</code>
        <title>HORIZON ERC Proof of Concept Grants</title>
        <description>HORIZON ERC Proof of Concept Grants</description>
        <displayCode readOnly="true">/HORIZON ERC Proof of Concept Grants</displayCode>
      </category>
      <category classification="source" type="isProvidedBy">
        <language>en</language>
        <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
        <code>/corda</code>
        <title>CORDA</title>
        <description>RTD research data warehouse</description>
        <displayCode readOnly="true">/CORDA</displayCode>
      </category>
    </categories>
  </relations>
</project>
